Clinical trial
Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse
NCT00190957 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00190957 |
|---|---|
| Title | Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse |
| Official title | Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ADHD, Comorbid Alcohol Abuse |
| Intervention type | Drug |
| Interventions | Atomoxetine, placebo |
| Enrollment | 140 |
| Start date | Aug 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 6, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: